| Literature DB >> 16021135 |
Richard A Krathen1, Sylvia Hsu.
Abstract
Atopic dermatitis has been associated with elevated levels of IgE. Omalizumab is a monoclonal anti-IgE antibody currently approved for the treatment of asthma. We report the failure of omalizumab to improve atopic dermatitis in 3 patients when administered for 4 months.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16021135 DOI: 10.1016/j.jaad.2005.02.014
Source DB: PubMed Journal: J Am Acad Dermatol ISSN: 0190-9622 Impact factor: 11.527